Literature DB >> 28492569

[Electromagnetic interference in the current era of cardiac implantable electronic devices designed for magnetic resonance environment].

Valentina Ribatti1, Luca Santini2, Giovanni B Forleo1, Domenico Della Rocca1, Germana Panattoni1, Marta Scali1, Valentina Schirripa2, Nicola Danisi2, Fabrizio Ammirati2, Massimo Santini3.   

Abstract

In the last decades we are observing a continuous increase in the number of patients wearing cardiac implantable electronic devices (CIEDs). At the same time, we face daily with a domestic and public environment featured more and more by the presence and the utilization of new emitters and finally, more medical procedures are based on electromagnetic fields as well. Therefore, the topic of the interaction of devices with electromagnetic interference (EMI) is increasingly a real and actual problem.In the medical environment most attention is paid to magnetic resonance, nevertheless the risk of interaction is present also with ionizing radiation, electrical nerve stimulation and electrosurgery. In the non-medical environment, most studies reported in the literature focused on mobile phones, metal detectors, as well as on headphones or digital players as potential EMI sources, but many other instruments and tools may be intentional or non-intentional sources of electromagnetic fields.CIED manufacturers are more and more focusing on new technological features in order to make implantable devices less susceptible to EMI. However, patients and emitter manufacturers should be aware that limitations exist and that there is not complete immunity to EMI.

Entities:  

Mesh:

Year:  2017        PMID: 28492569     DOI: 10.1714/2683.27472

Source DB:  PubMed          Journal:  G Ital Cardiol (Rome)        ISSN: 1827-6806


  1 in total

1.  Noise suppression ability and its mechanism analysis of scale-free spiking neural network under white Gaussian noise.

Authors:  Lei Guo; Enyu Kan; Youxi Wu; Huan Lv; Guizhi Xu
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.